Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.5M | $32.0M | $57.9M | $96.5M | $9.0M | $22.7M | $67.0M | $40.2M |
| Cost of revenue | $9.0M | $2.6M | $1.6M | $8.3M | $13.3M | $26.1M | $31.6M | $34.2M |
| Gross profit | $13.4M | $29.4M | $56.3M | $88.3M | −$4.3M | −$3.5M | $35.4M | $6.0M |
| Gross margin | 59.8% | 91.9% | 97.3% | 91.4% | -47.6% | -15.4% | 52.9% | 14.9% |
| R&D | $34.3M | $48.2M | $35.7M | $57.1M | $78.5M | $85.2M | $64.0M | $63.2M |
| Operating income | −$36.0M | −$26.2M | $14.2M | $20.4M | −$90.3M | −$92.7M | −$33.4M | −$69.3M |
| EBITDA | −$39.4M | −$47.6M | −$31.2M | −$22.3M | −$97.5M | −$101.6M | $17.5M | −$52.8M |
| Net income | −$35.1M | −$38.4M | −$27.6M | −$26.6M | −$92.1M | −$116.9M | −$59.6M | −$173.5M |
| Net margin | -156.2% | -119.7% | -47.7% | -27.5% | -1019.8% | -515.6% | -89.0% | -432.1% |
| EPS (diluted) | -1.13 | -1.17 | -0.75 | -0.70 | -2.25 | -2.69 | -1.22 | -2.51 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $155M | $0.62 | $0.62–$0.62 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds MITPF.
No tracked institution reports a position in MITPF as of their last filing.
No one on the platform has traded MITPF yet.
| +0.00% |
| $758M |
| — |
| DWRKFDrägerwerk AG & Co. KGaA | $543.70 | +0.00% | $1.8B | — |
| KARBFKaro Pharma AB (publ) | $5.25 | +0.00% | $1.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.